Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: Clin Endocrinol (Oxf). 2020 Apr 23;93(1):11–18. doi: 10.1111/cen.14188

Table 3.

Demographic and clinical characteristics of patients with ≥6 months of follow-up imaging.

Characteristic Total (n=163) <1.0 cm growth (n=135) ≥1.0 cm growth (n=26) P value

Male sex – no. (%) 97 (60) 79 (59) 16 (62) 0.77

Age – yr (range) 62 (27-86) 63 (28-86) 57 (27-86) 0.09

Mode of discovery – no. (%)
 Incidental 140 (86) 116 (86) 23 (89) 0.67
 Cancer staging 18 (11) 15 (11) 3 (11)
 Mass effect symptoms 5 (3) 4 (3) 0 (0)

Hemorrhage – no. (%) 5 (3) 1 (1) 3 (12) 0.007

Initial size (range) – cm 2.4 (0.5-18.0) 2.2 (0.5-13.3) 3.6 (0.8-18.0) 0.01

Adrenalectomy – no. (%) 14 (9) 5 (4) 9 (35) <.0001

Final size (range) – cm 2.6 (0.5-19.3) 2.3 (0.5-14.0) 5.9 (2.3-19.3) <.0001
Overall change in size (range) – mm 0 (−10, 115) 0 (−10, 95) 20 (10-115) <.0001
Rate of growth (range) – mm/yr 0 (−6, 14) 0 (−5.6, 14) 3.0 (1-11.0) <.0001